BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33826826)

  • 1. Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Apr; 384(14):e65. PubMed ID: 33826826
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    Edara VV; Pinsky BA; Suthar MS; Lai L; Davis-Gardner ME; Floyd K; Flowers MW; Wrammert J; Hussaini L; Ciric CR; Bechnak S; Stephens K; Graham BS; Bayat Mokhtari E; Mudvari P; Boritz E; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Douek DC; Sahoo MK; Sibai M; Solis D; Webby RJ; Jeevan T; Fabrizio TP
    N Engl J Med; 2021 Aug; 385(7):664-666. PubMed ID: 34233096
    [No Abstract]   [Full Text] [Related]  

  • 3. Audio Interview: How Well Are Covid-19 Vaccines Working?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102
    [No Abstract]   [Full Text] [Related]  

  • 4. Can immune responses predict which vaccines work best?
    Cohen J
    Science; 2021 Jul; 373(6551):142-143. PubMed ID: 34244387
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 6. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    Abbasi J
    JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Krammer F; Srivastava K; Alshammary H; Amoako AA; Awawda MH; Beach KF; Bermúdez-González MC; Bielak DA; Carreño JM; Chernet RL; Eaker LQ; Ferreri ED; Floda DL; Gleason CR; Hamburger JZ; Jiang K; Kleiner G; Jurczyszak D; Matthews JC; Mendez WA; Nabeel I; Mulder LCF; Raskin AJ; Russo KT; Salimbangon AT; Saksena M; Shin AS; Singh G; Sominsky LA; Stadlbauer D; Wajnberg A; Simon V
    N Engl J Med; 2021 Apr; 384(14):1372-1374. PubMed ID: 33691060
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
    Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
    [No Abstract]   [Full Text] [Related]  

  • 10. Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns.
    Cassaniti I; Percivalle E; Zelini P; Ngaradoumbe Nanhorngue K; Parolo A; Bernardi V; Jorizzo G; Santer P; Perotti F; Spinillo A; Lilleri D; Baldanti F
    Clin Microbiol Infect; 2021 Nov; 27(11):1708-1709. PubMed ID: 34371204
    [No Abstract]   [Full Text] [Related]  

  • 11. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    Edara VV; Hudson WH; Xie X; Ahmed R; Suthar MS
    JAMA; 2021 May; 325(18):1896-1898. PubMed ID: 33739374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic.
    Choe PG; Kim Y; Chang E; Kang CK; Kim NJ; Cho NH; Park WB; Oh MD
    J Korean Med Sci; 2022 Feb; 37(8):e67. PubMed ID: 35226425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
    Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
    Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
    [No Abstract]   [Full Text] [Related]  

  • 17. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 18. Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Dec; 383(27):e147. PubMed ID: 33382936
    [No Abstract]   [Full Text] [Related]  

  • 19. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.
    Joob B; Wiwanitkit V
    Clin Appl Thromb Hemost; 2021; 27():10760296211020833. PubMed ID: 34142570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.